Skip to main content
Ibogaine mechanism-based supportive approach for ALS and motor neuron disease at MindScape Retreat
ALS & Motor Neuron Disease. Cozumel, Mexico

Ibogaine for ALS
& Motor Neuron Disease

A mechanism-based approach to the neuroinflammation and loss of neurotrophic support seen in motor neuron disease. We are candid to a fault: ALS is a serious, progressive condition, and we do not claim to cure, stop, or slow it. What we offer is honest assessment and supportive care for those for whom it may be appropriate.

Book Your Free Consultation

100% Confidential · No Obligation

Anti-Inflam
Neuroinflammation Modulation
TNF-α and IL-6 reduction
GDNF
Neurotrophic Support
Motor neuron survival signaling
Neuroplasticity
Neural Compensation Support
Adaptive pathway formation
Screened
Candidacy Assessed First
Respiratory & cardiac safety gated
DA
Medically reviewed by Dr. Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 1,000 patients treated.
Last reviewed: May 2026 · See full medical team

The mechanism

Neuroinflammation, neurotrophic support, and motor neuron health

Amyotrophic lateral sclerosis (ALS) and related motor neuron diseases involve the progressive loss of the motor neurons that carry signals from the brain and spinal cord to the muscles. Chronic neuroinflammation and the loss of neurotrophic support, the biological signals that keep neurons alive, are increasingly recognized as part of that process.

Ibogaine acts on some of these same pathways: it reduces pro-inflammatory cytokines including TNF-alpha and IL-6, upregulates GDNF (a protein central to neuronal survival), and increases neuroplasticity. In principle, these mechanisms are biologically relevant to the environment motor neurons live in.

In practice, this is an emerging and complementary idea, not a treatment proven to change the course of ALS in clinical trials. We say that as plainly as we can. There is real biology here, and there is a great deal we do not know, and we will never let hope outrun the evidence.

Please read this carefully

What we do, and do not, promise

ALS is a serious and progressive disease. We do not claim to cure it, stop it, slow it, or reverse it. Anyone who promises a family that they can do those things should be treated with the deepest caution, because that promise cannot honestly be made.

What we can offer is a careful medical assessment, mechanism-based supportive care aimed at neural health and wellbeing, and complete honesty about the limits of what is known. For many people, and especially where breathing or swallowing is already affected, our answer will be that this program is not safe or appropriate, and we will tell you so directly.

The most important thing we can give a family facing ALS is the truth. If we cannot help someone safely and honestly, we will say no, even when it is the harder answer.

The approach

How the program supports neural health

Anti-Inflammatory Action

Reduction of the pro-inflammatory cytokines (TNF-α, IL-6) implicated in the neuroinflammatory environment around motor neurons.

GDNF Neurotrophic Support

Upregulation of Glial Cell-Derived Neurotrophic Factor, a protein central to the survival and maintenance of neurons.

Neuroplasticity & Wellbeing

Support for the nervous system's adaptive capacity, alongside attention to mood, meaning, and quality of life.

Respiratory & Cardiac Screening

Because ALS can affect breathing and ibogaine is cardio-active, we assess respiratory and cardiac function rigorously. Compromised breathing means the program is not appropriate.

Family Involvement

We involve the people who love and care for the person, and we keep expectations realistic and grounded throughout.

Measured, Not Assumed

Wellbeing and functional baselines are captured and re-measured, so anything we observe is tracked honestly rather than hoped for.

The process

A careful, safety-gated program

01

Candidacy & medical screening

Before anything else, our medical team reviews disease stage, respiratory and bulbar function, cardiac health, and capacity to consent. Where breathing is affected, the honest answer is no.

02

Neurotrophic priming

For appropriate candidates only, an extended anti-inflammatory and neurotrophic protocol under medical supervision.

03

Supervised session

The medically supervised session under continuous cardiac and respiratory monitoring.

04

Integration & honest measurement

Structured integration and re-measurement of wellbeing and function against baseline, with realistic, family-involved follow-up.

Measured & safe

Recovery you can track. Safety you can trust.

Our proprietary data system measures your progress before, during, and after your stay, and monitors your safety at every step. The same data that keeps you safe is the data that proves it worked.

Measured before you arrive

Validated instruments build your baseline before you travel.

Safety monitored throughout

Cardiac and vital monitoring around your session, read in real time.

Outcomes visible to you

Your progress re-scored against your baseline, in your portal.

Questions

ALS treatment, answered honestly

No. We do not claim to cure, stop, slow, or reverse ALS, and we urge families to be very cautious of any program that does. Ours is a complementary, mechanism-based approach aimed at supporting neural health and wellbeing for those for whom it is genuinely appropriate.

Often it is not. ALS can weaken the muscles used for breathing, and ibogaine is cardio-active and requires tolerating a long session. Where respiratory function is compromised, this program is not appropriate, and our medical team will say so.

Ibogaine's mechanisms (anti-inflammatory action, GDNF upregulation, neuroplasticity) are documented in research, and neuroinflammation is recognized in motor neuron disease. But this specific application is emerging, not established through clinical trials, and we are fully transparent about that.

Our medical team assesses disease stage, respiratory and bulbar function, cardiac and general health, medications, and the capacity to give informed consent. Safety and honesty come first, and we turn away anyone for whom the program is not safe or appropriate.

Begin

Talk with our medical team, honestly

A free, confidential consultation to review the situation and whether our program could be appropriate. No pressure, no false hope, and a candid answer either way.

Book Your Free Consultation

100% Confidential · No Obligation

Looking for ibogaine treatment for ALS and motor neuron disease accessible from your state? MindScape Retreat treats patients from across the US with direct flights to Cozumel. Find ibogaine treatment near you.